Cost of post-operative intravenous iron therapy in total lower limb Arthroplasty: A retrospective, matched cohort study

Blood Transfusion

Volumn 12, Issue 1, 2014, Pages 40-49

  Muñoz, Manuel ^a   Gómez Ramírez, Susana ^a   Martín Montañez, Elisa ^a   Naveira, Enrique ^b   Seara, Javier ^c   Pavía, José ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b Departments of Orthopaedic Surgery   (Spain)

^c Clinica Santa Elena   (Spain)

Author keywords

Allogeneic red cell transfusion; Cost effectiveness; Length of hospital stay; Lower limb arthroplasty.; Post operative intravenous iron

Indexed keywords

ARTHROPLASTY, REPLACEMENT; COSTS AND COST ANALYSIS; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; IRON; MALE; MIDDLE AGED; POSTOPERATIVE CARE; RETROSPECTIVE STUDIES;

EID: 84894140484     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2013.0088-13     Document Type: Article

References (43)

1. Bierbaum BE, Callaghan JJ, Galante JO, et al. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999; 81A: 2-10.
2. Rosencher N, Kerkkamp HE, Macheras G, et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003; 43: 459-69.
3. Sehat KR, Evans RL, Newman JH. Hidden blood loss following hip and knee arthroplasty. Correct management of blood loss should take hidden loss into account. J Bone Joint Surg Br 2004; 86-B: 561-5.
4. Gombotz H, Rehak PH, Shander A, Hofmann A. Blood use in elective surgery: the Austrian benchmark study. Transfusion 2007; 47: 1468-80.
5. British Committee for Standards in Haematology. Blood transfusion Task Force. Guidelines for the clinical use of red cell transfusion. Br J Haematol 2001; 113: 24-32.
6. Sociedad Española de Transfusión Sanguínea y Terapia Celular. Guía sobre la transfusión de componentes sanguíneos y derivados plasmáticos, 4th Ed. Madrid, SETS 2010: 43-54.
7. Liumbruno G, Bennardello F, Lattanzio A, et al. Recommendations for the transfusion of red blood cells. Blood Transfus 2009; 7: 49-64.
8. Liumbruno GM, Bennardello F, Lattanzio A, et al; Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) Working Party. Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period. Blood Transfus 2011; 9: 189-217.
9. Liumbruno GM, Bennardello F, Lattanzio A, et al; Italian Society of Transfusion Medicine and Immunohaematology Working Party. Recommendations for the transfusion management of patients in the peri-operative period. III. The post-operative period. Blood Transfus 2011; 9: 320-35.
10. Carson JL, Grossman BJ, Kleinman S, et al. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med 2012; 157: 49-58.
11. Muñoz M, García-Erce JA, Villar I, Thomas D. Blood conservation strategies in major orthopaedic surgery: efficacy, safety and European regulations. Vox Sang 2009; 96: 1-13.
12. Beris P, Muñoz M, García-Erce JA, et al. Perioperative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth 2008; 100: 599-604.
13. Cuenca J, García-Erce JA, Muñoz M, et al. Patients with pertrochanteric hip fracture may benefit from preoperative intravenous iron therapy: a pilot study. Transfusion 2004; 44: 1447-52.
14. Cuenca J, García-Erce JA, Martínez AA, et al. Role of parenteral iron in the management of anaemia in the elderly patient undergoing displaced subcapital hip fracture repair. Preliminary data. Arch Orthop Trauma Surg 2005; 125: 342-7.
15. García-Erce JA, Cuenca J, Muñoz M, et al. Perioperative stimulation of erythropoiesis with intravenous iron and erythropoietin reduces transfusion requirements in patients with hip fracture. A prospective observational study. Vox Sanguinis 2005; 88: 235-43.
16. Cuenca J, García-Erce JA, Martínez F, et al. Perioperative intravenous iron, with or without erythropoietin, plus restrictive transfusion protocol, reduce the need for allogeneic blood after knee replacement surgery. Transfusion 2006; 46: 1112-9.
17. Muñoz M, Naveira E, Seara J, et al. Role of parenteral iron in transfusion requirements after total hip replacement. A pilot study. Tranfus Med 2006; 16: 137-42.
18. Muñoz M, Naveira E, Seara J, Cordero J. Effects of postoperative intravenous iron on transfusion requirements after lower limb arthroplasty. Br J Anaesth 2012; 108: 532-4.
19. Serrano-Trenas JA, Font-Ugalde P, Muñoz-Cabello L, et al. Role of perioperative intravenous iron therapy in elderly hip fracture patients. A single center randomized controlled trial. Transfusion 2011; 51: 97-104.
20. Kaplan RS, Anderson SR. Time-driven activity-based costing. Harv Bus Rev 2004; 82: 131-8.
21. Muñoz M, Ariza D, Campos A, Martín-Montañez E, Pavía J. The cost of post-operative shed blood salvage after total knee arthroplasty: an analysis of 1,093 consecutive procedures. Blood Transfus 2013; 11: 260-71.
22. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Earlbaum Associates; 1988: 21-3.
23. Muñoz M, García-Erce JA, Cuenca J, et al. On the role of iron therapy for reducing allogeneic blood transfusion in orthopaedic surgery. Blood Transfus 2012; 10: 8-22.
24. Shander A, Hofmann A, Ozawa S, et al. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010; 50: 753-65.
25. Bhandari S. Update of a comparative analysis of cost minimization following the introduction of newly available intravenous iron therapies in hospital practice. Ther Clin Risk Manag 2011; 7: 501-9.
26. Kanavos P, Yfantopoulos J, Vandoros C, Politis C. The economics of blood: gift of life or a commodity? Int J Technol Assess Health Care 2006; 22: 338-43.
27. Toner RW, Pizzi L, Leas B, et al. Costs to hospitals of acquiring and processing blood in the US: a survey of hospital-based blood banks and transfusion services. Appl Health Econ Health Policy 2011; 9: 29-37.
28. Bisbe E, García-Erce JA, Díez-Lobo AI, Muñoz M. A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery. Br J Anaesth 2011; 107: 477-8.
29. Fragoulakis V, Kourlaba G, Goumenos D, et al. Economic evaluation of intravenous iron treatments in the management of anemia patients in Greece. Clinicoecon Outcomes Res 2012; 4: 127-34.
30. Rubio-Terrés C, Fernández-López A, Fernández-Montero A, et al. Análisis farmacoeconómico del tratamiento de la deficiencia de hierro con hierro carboximaltosa (Ferinject®) en España. Pharmacoeconomics (Spanish Research Articles) 2010; 7: 109-17.
31. Llewelyn CA, Taylor RS, Todd AA, et al. The effect of universal leukoreduction on postoperative infections and length of hospital stay in elective orthopedic and cardiac surgery. Transfusion 2004; 44: 489-500.
32. Bellamy MC, Gednaey JA. Unrecognised iron deficiency in critical illness. Lancet 1998; 352: 1903.
33. Muñoz M, García-Erce JA, Remacha AF. Disorders of iron metabolism. Part II: iron deficiency and iron overload. J Clin Pathol 2011; 64: 287-96.
34. Abraham I, Sun D. The cost of blood transfusion in Western Europe as estimated from six studies. Transfusion 2012; 52: 1983-8.
35. Chertow GM, Mason PD, Vaaga-Nilsen O, Ahlmén J. Update on adverse drug events associated with parenteral iron. Nephrol Dial Transplant 2006; 21: 378-82.
36. Stainsby D, Jones H, Asher D, et al; SHOT Steering Group. Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfus Med Rev 2006; 20: 273-82.
37. Coyne DW. It's time to compare anemia management strategies in hemodialysis. Clin J Am Soc Nephrol 2010; 5: 740-2.
38. Riedl R, Engels EA, Warren JL, et al. Blood transfusions and the subsequent risk of cancers in the United States elderly. Transfusion 2013 Jan 16. doi: 10.1111/trf.12071. [Epub ahead of print].
39. Fleiss JL. Determining sample sizes needed to detect a difference between two proportions; in: Fleiss JL, Lewin B, Chopaile M (eds): Statistical Methods for Rates and Proportions, 2nd ed. New York: Wiley, 1981: 38-45.
40. García-Erce JA, Cuenca J, Haman-Alcober S, et al. Efficacy of preoperative recombinant human erythropoietin administration for reducing transfusion requirements in patients undergoing surgery for hip fracture repair. An observational cohort study. Vox Sang 2009; 97: 260-7.
41. García-Erce JA, Cuenca J, Martínez F, et al. Perioperative intravenous iron preserves iron stores and may hasten the recovery from post-operative anaemia after knee replacement surgery. Transfus Med 2006; 16: 335-41.
42. Kotzé A, Carter LA, Scally AJ. Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle. Br J Anaesth 2012; 108: 943-52.
43. Bisbe E, Moltó L, Arroyo R, et al. The efficacy of intravenous iron for treating postoperative anemia and hastening functional recovery in patients undergoing total knee arthroplasty: preliminary results from a randomized controlled trial [Abstract]. Transfus Altern Transfus Med 2012; 12: 29-30.